Grifols Celebrates 50 Years In Clayton
Grifols, a global manufacturer of plasma-based medicines, celebrated its 50th anniversary in Clayton, North Carolina. The company's Clayton campus has grown significantly over the last five decades and now produces over 14 million vials of plasma medicines annually. The facility has contributed to Grifols becoming a top-three player in the plasma sector and accounts for approximately 40% of Grifols' global output. Additionally, it has played a role in producing medicines for public health crises such as Ebola and COVID-19. Keep reading to learn more about the success of this manufacturing site and how it has become a model of innovation and sustainability.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.